FDA Denies Marketing of Two Vuse Menthol E-Cigarette Products

VIEW TODAY’S NEWS RELEASE HERE

FDA announced the agency has issued marketing denial orders (MDOs) for two menthol e-cigarette products currently marketing by R.J. Reynolds Vapor Company – the Vuse Vibe Tank Menthol 3.0% and the Vuse Ciro Cartridge Menthol 1.5%.  The company must not market or distribute these products in the U.S. or they risk enforcement action by the FDA.

When reviewing premarket product applications (PMTAs), the agency evaluates, among other things, a tobacco product’s components, ingredients, additives, constituents, design, harmful and potentially harmful constituents, and health risks, as well as how the product is manufactured, packaged, and labeled.  After reviewing the company’s PMTAs, the FDA determined that the applications lacked sufficient evidence to demonstrate that permitting the marketing of the products would be appropriate for the protection of the public health, the applicable standard legally required by the 2009 Family Smoking Prevention and Tobacco Control Act.

Existing evidence demonstrates that non-tobacco-flavored e-cigarettes, including menthol flavored e-cigarettes, have a known and substantial risk with regard to youth appeal, uptake, and use; in contrast, data indicate tobacco-flavored e-cigarettes do not have the same appeal to youth and therefore do not pose the same degree of risk.  Given these existing differences in youth risk, applicants need to provide robust evidence to demonstrate that using their menthol flavored e-cigarette products are likely to promote complete switching or are likely to significantly reduce combustible cigarette use in adult smokers beyond that facilitated by tobacco-flavored e-cigarettes products.  Data from the 2022 National Youth Tobacco Survey found that Vuse was the second most common brand youth e-cigarette users reported “usually” using.

These products cannot be legally introduced into interstate commerce in the U.S. without risking FDA enforcement.  In addition to ensuring that the manufacturer complies with this order, as with unauthorized products generally, the FDA intends to ensure compliance by distributors and retailers.  Retailers should contact R.J. Reynolds Vapor Company with any questions about products in their inventory.

VIEW TODAY’S NEWS RELEASE HERE

×

Upcoming Events

Attending any of these upcoming events? Have other events to share? Let us know! Email us at NNN@ITCMI.ORG to share your event information or to get on our list serve for event updates.

 

National Network of Public Health Institutes Annual Conference | New Orleans, LA | LEARN MORE AND REGISTER

2026 National Council of Urban Indian Health Conference | Washington, D.C. | LEARN MORE AND REGISTER

Webinar | Behavioral Health and Tobacco Product Use:  Addressing Disparities, Improving Outcomes | LEARN MORE AND REGISTER

Partners in Chronic Disease Prevention Symposium | Hosted by Great Plains Tribal Health | Great Plains Tribal Health is pleased to announce that registration is now open for the Partners in Chronic Disease Prevention Symposium. Travel scholarships are available on a first-come, first-served basis.  To apply for a scholarship, please indicate so on the registration page and return all necessary documents by April 10, 2026. | ATTENDEE REGISTRATION | VENDOR REGISTRATION

Council of State and Territorial Epidemiologists Annual Conference | Boston, MA | LEARN MORE AND REGISTER

National Tribal Tobacco Conference | June 23, 2026 | Minneapolis, MN | LEARN MORE AND REGISTER

Jiimaan Journey | LEARN MORE

Great Lakes Area Tribal Public Health Conference | LEARN MORE